2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 Wiley 2026暑期线上学习营 | 报名正式开启! | 热 最高IF18.6!生命科学SCI明星期刊集锦 | 热 肿瘤免疫/自身免疫全覆盖|免疫学SCI期刊列表 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Cancer Medicine CANCER MED-US (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.3
70人评分
我要评分
声誉 6.8 影响力 5.4 速度 7.6 | |||||||||||||||||||||||||
| 期刊ISSN | 2045-7634 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:3.42 | |||||||||||||||||||||||||
| 2025-2026自引率 | 2.9%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年IF (数据来源于网友提供) | 3.597数据由网友[hack8215]收集提供 | |||||||||||||||||||||||||
| h-index | 34 | |||||||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634 | |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | https://mc.manuscriptcentral.com/cancermedicine | |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta-Analyses Author: Yu, Zhengyu; Wang, Zhongwang; Xie, Li; Xu, Jing; Min, Lang; Li, Lingfeng; Niu, Ting Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cam4.71880 Neoadjuvant Chemotherapy for Male Breast Cancer: A Retrospective Cohort Study Author: Yang, Zejian; Ni, Peng; Wang, Yu; Wang, Ruixin; Wang, Bo; Ren, Yu; Ge, Guanqun; Liu, Fan; He, Jianjun; Zhou, Can Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cam4.71987 Clinical Characteristics, Treatment Patterns, and Prognosis of Central Nervous System Involvement in Multiple Myeloma: A Multicenter Retrospective Study From China Author: Li, Wenjing; Tian, Weiwei; Ma, Jie; Li, Linyu; Li, Zhihua; Liu, Jie; Gao, Guorong; Xi, Zhenfang; Zhang, Lan; Zhang, Weihua; Duan, Lixiang; Geng, Hui; Meng, Jie; Zhu, Honghu; Chen, Wenming; Gao, Wen Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cam4.71986 FKBP9 Enhances Colon Cancer Cell Proliferation by Inhibiting GPX4-Mediated Ferroptosis Author: Deng, Jianzhong; Jiang, Anqi; Zhang, Xizheng; Wei, Jiayu; Liu, Qian; Shen, Ying; Hua, Dong Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cam4.71772 | |||||||||||||||||||||||||
| 期刊语言要求 | Language Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Medicine的语言要求,还能让Cancer Medicine编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Medicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(7篇) 。 提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD4070; GBP2640; EUR3080; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:cancer biology、cancer medicine、cancer prevention、bioinformatics 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||
| 通讯方式 | 111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774 | |||||||||||||||||||||||||
| 出版商 | John Wiley and Sons Ltd | |||||||||||||||||||||||||
| 涉及的研究方向 | ONCOLOGY- | |||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||||||
| 年文章数 | 924点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 84.96% | |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2045-7634%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 19 Weeks | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验: | |||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费:需要( USD4070; GBP2640; EUR3080; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Cancer Medicine顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(7篇) 。 提交文稿 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta-Analyses Author: Yu, Zhengyu; Wang, Zhongwang; Xie, Li; Xu, Jing; Min, Lang; Li, Lingfeng; Niu, Ting Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cam4.71880 PubMed DOI |
| 2. | Neoadjuvant Chemotherapy for Male Breast Cancer: A Retrospective Cohort Study Author: Yang, Zejian; Ni, Peng; Wang, Yu; Wang, Ruixin; Wang, Bo; Ren, Yu; Ge, Guanqun; Liu, Fan; He, Jianjun; Zhou, Can Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cam4.71987 PubMed DOI |
| 3. | Clinical Characteristics, Treatment Patterns, and Prognosis of Central Nervous System Involvement in Multiple Myeloma: A Multicenter Retrospective Study From China Author: Li, Wenjing; Tian, Weiwei; Ma, Jie; Li, Linyu; Li, Zhihua; Liu, Jie; Gao, Guorong; Xi, Zhenfang; Zhang, Lan; Zhang, Weihua; Duan, Lixiang; Geng, Hui; Meng, Jie; Zhu, Honghu; Chen, Wenming; Gao, Wen Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cam4.71986 PubMed DOI |
| 4. | FKBP9 Enhances Colon Cancer Cell Proliferation by Inhibiting GPX4-Mediated Ferroptosis Author: Deng, Jianzhong; Jiang, Anqi; Zhang, Xizheng; Wei, Jiayu; Liu, Qian; Shen, Ying; Hua, Dong Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cam4.71772 PubMed DOI |
| 5. | Real-World Efficacy of Metronomic Chemotherapy in Advanced Breast Cancer Across Molecular Subtypes Author: Zhou, Hanxing; Chen, Linmin; Lu, Qianyi; Wu, Huailiang; Jiang, Kuikui; Xu, Fei; Wang, Shusen Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 6, pp. -. DOI: 10.1002/cam4.71961 PubMed DOI |
| 6. | Neoplasm Adverse Events Associated With Anti-Type 2 Biologics: An FAERS Database Pharmacovigilance Analysis Study Author: Lyu, Wen; Xu, Rui; Chen, Lin; Lei, Wenbin; Chen, Changhui; Liao, Jiaqi; Lin, Xingyu; Ma, Renqiang; Wen, Weiping; Li, Hang Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71979 PubMed DOI |
| 7. | Camrelizumab Plus Famitinib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Study Author: Xu, Bei; Zhu, Guopei; Lu, Jin; Zhang, Ximei; Chen, Xiaozhong; Liu, Qinjiang; Qu, Song; Fan, Jia; Liu, Tianshu Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71899 PubMed DOI |
| 8. | Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer Author: Li, Yongsheng; Yuan, Li; Lou, Ge; Cai, Hongbing; Li, Yuzhi; Li, Fenghu; Wang, Li; Long, Xingtao; Gong, Yi; Zhu, Chaonan; Li, Li; Xu, June; Zhou, Qi Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71704 PubMed DOI |
| 9. | METTL16 Promotes Head and Neck Squamous Cell Carcinoma Progression via m6A-Mediated Stabilization of SREBP2 mRNA and Enhanced Cholesterol Biosynthesis Author: Ma, Xinrui; Ding, Xiaojun; Deng, Jianhua; Gao, Qian; Liu, Huiting; Yuan, Shuo; Xiao, Zhi; Jiang, Rui Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71917 PubMed DOI |
| 10. | Prognostic Value and Therapeutic Implications of MRI-Based Negative Lymph Nodes in Nasopharyngeal Carcinoma Author: Lin, Ze-Qi; He, Chu-Yu; He, Shui-Qing; Dai, Dong-Yu; Yang, Kai-Bin; Li, Ji-Bin; Liu, Li-Zhi; Huang, Ying; Zhang, Yuan; Liu, Xu; Ma, Jun; Liu, Jia-Ni; Xu, Cheng Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71953 PubMed DOI |
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共1344条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室